Annual report pursuant to Section 13 and 15(d)

Consolidated Balance Sheets

v3.22.1
Consolidated Balance Sheets - USD ($)
$ in Thousands
Dec. 31, 2021
Dec. 31, 2020
Current assets:    
Cash and cash equivalents $ 24,534 $ 16,399
Prepaids and other current assets 1,314 1,269
Short-term investments 219 0
Total current assets 26,067 17,668
Property and equipment, net 10 14
Total assets 26,077 17,682
Current liabilities:    
Accounts payable 1,584 1,214
Accrued expenses 1,733 1,971
Short-term loan 538 0
Total current liabilities 3,855 3,185
Warrant liabilities 0 27,964
Total liabilities 3,855 31,149
Commitments and contingencies (Note 3 and Note 9)
Stockholders' equity (deficit)    
Preferred stock, par value $0.0001; 10,000,000 shares authorized as of December 31, 2021 and 2020; no shares issued and outstanding at December 31, 2021 and 2020. 0 0
Common stock, par value $0.0001; 75,000,000 shares authorized as of December 31, 2021 and 2020; 18,845,828 and 10,882,495 shares issued and outstanding at December 31, 2021 and 2020, respectively. 2 1
Additional paid-in-capital 111,588 19,207
Accumulated deficit (89,368) (32,675)
Total stockholders' equity (deficit) 22,222 (13,467)
Total liabilities and stockholders' equity (deficit) $ 26,077 $ 17,682